These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
702 related items for PubMed ID: 26186609
1. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy. O'Connor JL, Gardner EM, Esser S, Mannheimer SB, Lifson AR, Telzak EE, Phillips AN, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategies for Management of Antiretroviral Therapy (SMART) Study Group. HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609 [Abstract] [Full Text] [Related]
2. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression. Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Holloway J, Johnson M, Phillips AN. HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781 [Abstract] [Full Text] [Related]
3. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy. Geretti AM, Smith C, Haberl A, Garcia-Diaz A, Nebbia G, Johnson M, Phillips A, Staszewski S. Antivir Ther; 2008 Mar; 13(7):927-36. PubMed ID: 19043927 [Abstract] [Full Text] [Related]
5. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City. Robertson M, Laraque F, Mavronicolas H, Braunstein S, Torian L. AIDS Care; 2015 Mar; 27(2):260-7. PubMed ID: 25244545 [Abstract] [Full Text] [Related]
6. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa. Teasdale CA, Sogaula N, Yuengling KA, Wang C, Mutiti A, Arpadi S, Nxele M, Pepeta L, Mogashoa M, Rivadeneira ED, Abrams EJ. J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952 [Abstract] [Full Text] [Related]
9. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa. Shoko C, Chikobvu D, Bessong PO. S Afr Med J; 2020 Mar 30; 110(4):313-319. PubMed ID: 32657744 [Abstract] [Full Text] [Related]
10. Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study. Farmer A, Wang X, Ganesan A, Deiss RG, Agan BK, O'Bryan TA, Akers K, Okulicz JF. AIDS Res Ther; 2016 Mar 30; 13():16. PubMed ID: 27006682 [Abstract] [Full Text] [Related]
13. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda. Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C, Nanfuka M, Nyonyintono MS, Kim J, Zhu J, Kaleebu P, Moore DM. HIV Med; 2020 Jan 30; 21(1):21-29. PubMed ID: 31432614 [Abstract] [Full Text] [Related]
20. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. Sherr L, Lampe FC, Clucas C, Johnson M, Fisher M, Leake Date H, Anderson J, Edwards S, Smith CJ, Hill T, Harding R. AIDS Care; 2010 Aug 29; 22(8):939-45. PubMed ID: 20574863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]